Results 271 to 280 of about 310,082 (306)

G-CSF: filgrastim, lenograstim and biosimilars

Expert Opinion on Biological Therapy, 2014
The identification, purification and molecular cloning of granulocyte colony-stimulating factor G-CSF in the 1980s; the nonclinical studies in the mid-1980s; and the subsequent development of G-CSF as a therapeutic agent in the late 1980s and 1990s have had a major influence on the treatment of many diseases.
openaire   +2 more sources

The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus

Cell, 2023
Benjamin C Reeves, Phan Q Duy, Jinwei Zhang   +2 more
exaly  

G-CSF

Inpharma Weekly, 1991
openaire   +2 more sources

G-CSF

1998
Tak W. Mak, Josef Penninger, John Roder, Janet Rossant, Mary Saunders   +4 more
openaire   +1 more source

Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17

Nature, 2022
Fabian Kern, Achint Kaur, Saket Myneni
exaly  

G‐CSF after PBSC transplantation

British Journal of Haematology, 1998
E, Ojeda, J, Garcia-Bustos, M J, Aguado, M R, Luaces, R, Arrieta, F, Hernandez-Navarro   +5 more
openaire   +2 more sources

G-CSF

2006
openaire   +2 more sources

G-CSF

2001
Katherine A. Fitzgerald, Luke A.J. O'Neill, Andy J.H. Gearing, Robin E. Callard   +3 more
openaire   +1 more source

Filgrastim (G-CSF)

2007
S.J. Enna, David B. Bylund
openaire   +1 more source

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

Lancet, The, 1992
William P Sheridan
exaly